Summary
To elucidate the diabetogenic effect of growth hormone on glucose metabolism the regulation of glucose transporter (GLUT) gene expression was examined in rat skeletal muscles. Female Wistar-Furth rats were implanted subcutaneously with growth-hormone-producing pituitary tumour (GH3) cells. Animals were killed 4 or 9 weeks after GH3 cell injection. Although body weight, serum growth hormone and insulin-like growth factor I levels were remarkably elevated during the 4–9 week period, serum blood glucose levels were within normal range. Muscles were obtained from the quadriceps muscle, diaphragm and heart, respectively. Northern blot analysis and Western blot analysis were performed using specific cDNA probes and antibodies. During the 4–9 week period, the levels of muscle GLUT 1 and 4 mRNA (corrected by β-actin mRNA level) in each muscle from the rats injected with tumour cells were not significantly different from those of control rats. Chronic elevation of growth hormone in these rats did not cause any change in GLUT1 and 4 expression compared to the controls during the euglycaemic period. These results provide the first evidence that chronic growth hormone elevation itself does not affect a key gene of in vivo glucose metabolism.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Melmed S (1990) Acromegaly. N Engl J Med 322: 966–977
Davidson MB (1987) Effect of growth hormone on carbohydrate and lipid metabolism. Endocrine Rev 8: 115–131
Sönksen PH, Greenwood FC, Ellis JP, Lowy C, Rutterford A, Nabarro JDM (1967) Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response of treatment. J Clin Endocrinol Metab 27: 1418–1430
Beck P, Schalch DS, Parker ML (1965) Correlative studies of growth hormone and plasma insulin concentrations with metabolic abnormalities in acromegaly. J Lab Clin Med 66: 366–379
Jadresic A, Banks LM, Child DF, Diamant L, Doyle FH, Joplin GF (1982) The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary turnovers. Q J Med 202: 189–204
Flier JS, Moses AC (1989) Diabetes in acromegaly and other endocrine disorders. In: DeGroot LJ, Besser GM, Cahill GF, et al. (eds) Endocrinology, vol 2. WB Saunders Co., Philadelphia, pp 1389–1399
MacGorman LR, Rizza RA, Gerich JE (1981) Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. J Clin Endocrinol Metab 53: 556–559
Daughaday WH, Kipnis DM (1966) The growth promoting and anti-insulin action of somatotropin. Rec Prog Horm Res 22: 49–93
Zahnd GR, Steinke J, Renold AE (1960) Early metabolic effects of human growth hormone. Proc Soc Exp Biol Med 105: 455–470
Vaitkus P Sirek A, Norwich KH, Strek OV, Unger RH, Harris V (1984) Rapid changes in hepatic glucose output after a pulse of growth hormone in dogs. Am J Physiol 246: E14-E20
Rizza RA, Mandarino LJ, Gerich JE (1982) Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31: 663–669
Martin JM, Gagliardino JJ (1967) Effect of growth hormone on the isolated pancreatic islets of rat in vitro. Nature 213: 630–631
Muggeo M, Bar RS, Roth J (1977) Changes in affinity of insulin receptors following oral glucose in normal adults. J Clin Endocrinol Metab 44: 1206–1209
Bates RW, Garrison MM (1967) Quantitative study of the diabetogenic action of ACTH and growth hormone in partially pancreatectomized rats. Endocrinology 81: 527–534
Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R (1986) Insulin resistance in acromegaly: defect in both hepatic and extrahepatic insulin action. Am J Physiol 250: E269-E273
James DE, Brown R, Navarro J, Pilch PF (1988) Insulin-regulatable tissues express a unique insulin sensitive glucose transport protein. Nature 333: 183–185
Morgan HE, Cadenas E, Regern DM, Park CR (1961) Regulation of glucose uptake in muscle. 2, Rate limiting steps and effect. J Biol Chem 236: 262–268
Bell G, Kayano T, Buse JB et al. (1990) Molecular biology of mammalian glucose transporters. Diabetes Care 13: 198–243
Fukumoto H, Seino S, Imura H, Seino Y, Bell GI (1998) Characterization and expression of human HepG2/erythrocyte glucosetransporter gene. Diabetes 37: 657–661
Fukumoto H, Seino S, Imura H et al. (1988) Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc Natl Acad Sci USA 85: 5434–5438
Thorens B, Sarkar HK, Kaback HR, Lodish HF (1988) Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells. Cell 55: 281–290
Orci L, Thorens B, Ravazzola M, Lodish HF (1989) Localization of the pancreatic beta cell glucose transporter to specific plasma membrane domains. Science 245: 295–297
Permutt MA, Koranyi L, Keller K, Lacy PE, Scharp DW, Mueckler M (1989) Cloning and functional expression of a human pancreatic islet glucose-transporter cDNA. Proc Natl Acad Sci USA 86: 8688–8692
Chen L, Alam T, Johnson JH, Hughes S, Newgard CB, Unger RH (1990) Regulation of β-cell glucose transporter gene expression. Proc Natl Acad Sci USA 87: 4088–4092
Johnson JH, Newgard CB, Milburn JL, Lodish HF, Thorens B (1990) The high K glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence. J Biol Chem 265: 6548–6551
Harakawa S, Yamashita S, Tobinaga T et al. (1990) In vivo regulation of hepatic insulin-like growth factor-I mRNA with thyroid hormone. Endocrinol Jpn 37: 205–211
Tashjian AH (1979) Clonal strains of hormone-producing pituitary cells. Methods Enzymol 58: 527–535
Yamashita S, Slanina S, Kado H, Melmed S (1986) Autoregulation of pituitary growth hormone messenger ribonucleic acid levels in rats bearing transplantable mammosomatotrophic pituitary tumours. Endocrinology 118: 915–918
Chomcznski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Analyt Biochem 162: 156–159
Yamashita S, Melmed S (1986) Effects of insulin on rat anterior pituitary cells: inhibition of growth hormone secretion and mRNA levels. Diabetes 35: 440–447
Yamashita S, Tobinaga T, Ashizawa K et al. (1988) Glucose stimulation of protooncogene expression and deoxyribonucleic acid synthesis in rat islet cell line. Endocrinology 123: 1825–1829
Flier JS, Mueckler M, McCall AL, Lodish HF (1987) Distribution of glucose transporter messenger RNA transcripts in tissue of rat and man. J Clin Invest 79: 657–661
James DE, Strube M, Mueckler M (1989) Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338: 83–87
Ponte P, Gunning P, Blau M, Kedes L (1983) Human actin genes are single copy for α-skeletal and α-cardiac actin but multicopy for β and γ-cytoskeletal genes: 3′-untranslated regions are isotope specific but are conserved in evolution. Mol Cell Biol 3: 1783–1791
Lin JL, Asano T, Shibasaki Y et al. (1991) Altered expression of glucose transporter isoforms with aging in rats—selective decrease in GLUT4 in the fat tissue and skeletal muscle. Diabetologia 34: 477–482
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685
Takeda S, Podskalny I, Gorden P (1984) Direct effect of human growth hormone to inhibit glucose uptake in cultured human fibroblasts. Metabolism 33: 658–661
Silverman MS, Mynarcik DC, Corin RE, Haspel HC, Sonenberg M (1989) Antagonism by growth hormone of insulin-sensitive hexose transport in 3T3-F442A adipocytes. Endocrinology 125: 2600–2604
Davidson MB, Shen DC, Venkatesan N, Sladen G (1987) In vivo insulin antagonism but evanescent in vitro tissue effect in rats with growth hormone-secreting tumors. J Endocrinol Invest 10: 569–574
Bates RW, Scow RO, Lacy PE (1966) Induction of permanent diabetes in rats by pituitary hormones from a transplantable mammotropic tumour. Concomitant changes in organ weight and the effects of adrenectomy. Endocrinology 78: 826–831
Kahn BB, Rossetti L, Lodish HF, Charron MJ (1991) Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats. J Clin Invest 87: 2197–2206
Richardson JM, Balon TW, Treadway JL, Pessin JE (1991) Differential regulation of glucose transporter activity and expression in red and white skeletal muscle. J Biol Chem 266: 12690–12694
Pedersen O, Bak JF, Andersen PH et al. (1990) Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865–870
Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J (1990) Expression of insulin regulatable glucose transporter in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33: 625–627
Cuendet GS, Loten ER, Jeanrenaud B, Renold AE (1976) Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice. J Clin Invest 58: 1078–1088
Koranyi L, James D, Mueckler M, Permutt MA (1990) Glucose transporter levels in spontaneously obese (db/db) insulin resistant mice. J Clin Invest 85: 962–967
Dohm GL, Elton CW, Friedman JE et al. (1991) Decreased expression of glucose transporter in muscle from insulin-resistant patients. Am J Physiol 260: E459-E463
Tai P-KK, Liao J-F, Chen EH, Dietz J, Schwartz J, Carter-Su C (1990) Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells. J Biol Chem 265: 21828–21834
Walker PS, Ramlal T, Donovan JA et al. (1989) Insulin and glucose-dependent regulation of the glucose transport system in the rat L6 skeletal muscle cell line J Biol Chem 264: 6587–6595
Venkatesan N, Davidson MB (1990) Insulin-like growth factor I receptors in adult rat liver: characterization and in vivo regulation. Am J Physiol 258: E329-E337
Santalucia T, Camps M, Castello A et al. (1992) Developmental regulation of GLUT 1 (Eryhtrocyte/Hep G2) and GLUT4 (muscle/Fat) glucose transporter expression in rat heart, skeletal, and brown adipose tissue. Endocrinology 130: 837–846
Kahn BB, Rosen AS, Bak JF et al. (1992) Expression of GLUT 1 and GLUT 4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effect of metabolic factors. J Clin Endocrinol Metab 74: 1101–1109
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Imamura, H., Morimoto, I., Etoh, S. et al. Skeletal muscle glucose transporter gene expression is not affected by injecting growth-hormone-secreting cells in young rats. Diabetologia 36, 475–480 (1993). https://doi.org/10.1007/BF02743260
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02743260